Odevixibat

Overview

Odevixibat (A4250) is a selective and orally active ileal apical sodium-dependent bile acid transporter ( ASBT ) inhibitor. Odevixibat decreases cholestatic liver and bile duct injury in mice model. Odevixibat has the potential for the treatment of primary biliary cirrhosis.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Apical Sodium-Dependent Bile Acid Transporter

Product Information

• Catalog No.: HY-109120
• CAS No.: 501692-44-0
• Molecular Formula: C37H48N4O8S2
• Molecular Weight: 740.93
• Purity: 99.88%
• Storage: -20°C, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
• Solubility: ≥ 4.17 mg/mL (5.63 mM); Clear solution
• Availability: In-stock

Source

Original product source